Neuca, PLTRFRM00018

Neuca contests PLN 500.9 million fine and Neuca stock costs EUR 162.10

Published on 10/15/2026 at 14:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Neuca stock costs EUR 162.10 on October 15, 2026 at Lang & Schwarz. Neuca contests a PLN 500.9 million fine dated September 21, 2026.

Regulatory dispute and valuation

  • Neuca challenged the PLN 500.9 million fine on September 21, 2026.
  • Neuca's market capitalization was PLN 3.6 billion on September 21, 2026.
  • Neuca stock trades at EUR 162.10 at 2:00 p.m. CEST at Lang & Schwarz on October 15, 2026.
Neuca, PLTRFRM00018, Illustration mit AI erstellt.

Neuca (PLTRFRM00018) was trading at EUR 162.10 at Lang & Schwarz on October 15, 2026, while the company contests a PLN 500.9 million competition fine imposed in September. The dispute remains the clearest company-specific issue for the Polish pharmaceutical wholesaler.

Fine drives the company story

According to BIZNES24 on September 21, 2026, Neuca rejected the allegations and said it would appeal to the Polish Competition and Consumer Protection Court. The penalty concerns Neuca and its subsidiary Swiat Zdrowia in a case involving alleged restrictions on wholesale drug pricing.

The same report said the regulator had imposed total fines of PLN 905 million on four pharmaceutical companies. For Neuca, the stated amount was PLN 500.9 million, while the final amount and payment timing depend on the appeal process.

What does the fine mean?

The immediate financial reference is the PLN 500.9 million penalty, not a recognized final cash outflow. The legal outcome therefore matters for the eventual balance-sheet impact and for how investors assess the group's wholesale distribution business.

Health care remains the base

Neuca describes itself as Poland's largest pharmaceutical wholesaler and says it supplies medicines to almost all pharmacies in the country, according to Neuca. The group also operates in medical clinics, clinical research, telemedicine and health insurance.

Eulerpool placed Neuca's market capitalization at PLN 3.56 billion on September 21, 2026, linking the valuation to ticker NEU.WA and the Warsaw exchange. That figure provides a useful scale comparison with the disputed penalty, which equals 14.07 percent of the reported market value.

Stock quote after the Xetra close

Neuca's primary listing is on the Warsaw Stock Exchange, where the finance data showed NEU.WA at PLN 708 on October 15, 2026. The Lang & Schwarz euro quote provides the German investor perspective, while the legal dispute supplies the main company context.

The stock was trading at EUR 162.10 at Lang & Schwarz on October 15, 2026 at 2:00 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Neuca stock.

Neuca stock facts

  • Company: Neuca S.A.
  • ISIN: PLTRFRM00018
  • Ticker: NEU.WA
  • Primary exchange: GPW
  • Price Lang & Schwarz (as of October 15, 2026, 2:00 p.m. CEST): EUR 162.10
  • Market capitalization: PLN 3.6 billion (as of September 21, 2026)
  • Sector / Industry: Health Care

Market context: Market report WIG 20.

More news and analyses on Neuca stock

Disclaimer...
en | PLTRFRM00018 | NEUCA | boerse | 70329969 | bgmi